Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jussi Oskari Virtanen"'
Publikováno v:
Journal of Pediatric Infectious Diseases. :137-142
Human herpesvirus 6 (HHV-6) is a highly neuro- and lymphotropic virus with an increasing number of diseases associated with it. Most children are infected at the age of 6 to 15 months. Primary infection manifests classically as exanthema subitum. Thi
Publikováno v:
Multiple Sclerosis Journal. 20:27-34
Background: Two human herpesviruses, human herpesvirus 6 (HHV-6), and Epstein-Barr virus (EBV), have been repeatedly linked to multiple sclerosis (MS). Objective: The aim of this study was to investigate HHV-6 and EBV reactive oligoclonal bands (OCBs
Autor:
Jenna Pietiläinen-Nicklén, Markus Färkkilä, Jussi Oskari Virtanen, Lasse Uotila, Marjaleena Koskiniemi, Antti Vaheri
Publikováno v:
Journal of Neuroimmunology. 237:93-97
Demyelinating diseases of the central nervous system (CNS) often include elevated IgG production in intrathecal space presenting as oligoclonal bands (OCBs) in cerebrospinal fluid (CSF). In most demyelinating diseases, e.g. in multiple sclerosis (MS)
Autor:
Jussi Oskari Virtanen, Riitta Lassila, Tapani Ruutu, Liisa Volin, M. Lemponen, A Pinomäki, Lotta Joutsi-Korhonen
Publikováno v:
Bone Marrow Transplantation. 45:730-737
The evolution of coagulation and fibrinolysis has not been thoroughly evaluated in allogeneic SCT. In this pilot study, we characterized the adaptive mechanisms of coagulation and fibrinolysis during allogeneic SCT and 3-month follow-up and studied p
Autor:
Jussi Oskari Virtanen, J. Pietiläinen, Markus Färkkilä, Marjaleena Koskiniemi, Lasse Uotila, Oili Salonen
Publikováno v:
European Journal of Neurology. 17:506-509
Background and purpose: To elucidate the role of human herpesvirus-6 (HHV-6) in the development of multiple sclerosis (MS). Patients and methods: Nine patients with MS and with acute or chronic HHV-6 infection were evaluated. Results: Intrathecal ant
Autor:
Marjaleena Koskiniemi, Markus Färkkilä, Jenna Pietiläinen-Nicklén, Lasse Uotila, Oili Salonen, Jussi Oskari Virtanen
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 61(2)
Background The triggering agent of multiple sclerosis is still unknown and many viruses, including human herpesvirus-6 (HHV-6), are under suspicion. In earlier study we found patients who had HHV-6 reactive OCBs in their CSF. We wanted to investigate
Autor:
Steve Jacobson, Jussi Oskari Virtanen
Multiple sclerosis (MS) is a heterogeneous disease that develops as an interplay between the immune system and environmental stimuli in genetically susceptible individuals. There is increasing evidence that viruses may play a role in MS pathogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a03c7e3e8695c0d003511563dfee55a
https://europepmc.org/articles/PMC4758194/
https://europepmc.org/articles/PMC4758194/
Autor:
Janica Djupsjöbacka, Alexander Plyusnin, Antti Vaheri, Kirsi M. Jääskeläinen, Jussi Oskari Virtanen
Publikováno v:
Archives of virology. 155(1)
The small RNA segment of some hantaviruses (family Bunyaviridae) encodes two proteins: the nucleocapsid protein and, in an overlapping reading frame, a non-structural (NSs) protein. The hantavirus NSs protein, like those of orthobunya- and phleboviru
Autor:
Eila Herrgård, Jussi Oskari Virtanen, Antti Vaheri, Anna Fogdell-Hahn, Jenny Ahlqvist, Marjaleena Koskiniemi, Valmari P
Publikováno v:
Neuropediatrics. 38(6)
HHV-6 infection has been associated with neurological symptoms in children. Two variants of human herpes virus 6, HHV-6A and HHV-6B, have been identified. Their role in neurological infections is poorly understood. We studied 53 children with suspect
Autor:
Antti Vaheri, Markus Färkkilä, Anne J. Jääskeläinen, Jussi Oskari Virtanen, Lasse Uotila, Marjaleena Koskiniemi, Juha Multanen
Publikováno v:
Journal of neurovirology. 13(4)
Human herpesvirus 6 (HHV-6) has been linked to the pathogenesis of multiple sclerosis (MS). HHV-6 antibodies in serum and cerebrospinal fluid (CSF) of 27 patients with clinically definite MS (CDMS) were compared with age- and sex-matched controls, in